Lundbeck
Lundbeck is a global pharmaceutical company specialized in brain diseases.
Launch date
Employees
Market cap
$6.5b
Enterprise valuation
$5.9b (Public information from Sep 2024)
Share price
DKK39.45 LUN.CO
Copenhagen Capital Region of Denmark (HQ)
Corporate Venture Fund: Lundbeckfonden Ventures
No columns specified